Scientists from the United Kingdom have developed a simple blood test to detect Parkinson’s disease, at its earliest stages. David Allsop, from the University of Lancaster, and colleagues studied a group of people diagnosed with Parkinson’s disease, and a second group of healthy people of a similar age. Blood samples from each group were analyzed to determine the levels of phosphorylated alpha-synuclein present. They found those with Parkinson’s disease had increased levels of the substance. Based upon these findings, researchers developed a blood test that detects the presence of phosphorylated alpha-synuclein, which could allow for diagnosis of the disease well before symptoms appear but when brain damage has already begun to occur. Writing that: “phosphorylated [alpha-synuclein] can be detected in blood plasma and shows more promise as a diagnostic marker,” the study authors urge for: “Longitudinal studies … to determine whether [alpha-synuclein] can act as a marker of disease progression.”
Simple Blood Test Diagnoses Parkinson’s Disease At Earliest Stages
Penelope G. Foulds, J. Douglas Mitchell, Angela Parker, Roisin Turner, Gerwyn Green, David Allsop, et al. “Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.” FASEB J., December 2011, 25:4127-4137.
RELATED ARTICLES